Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NSE - Delayed Quote INR

IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS)

Compare
61.65
+2.30
+(3.88%)
At close: 3:29:57 PM GMT+5:30
Loading Chart for IOLCP.NS
  • Previous Close 59.35
  • Open 61.99
  • Bid 61.65 x --
  • Ask --
  • Day's Range 60.14 - 61.99
  • 52 Week Range 57.50 - 107.54
  • Volume 581,791
  • Avg. Volume 1,069,460
  • Market Cap (intraday) 18.096B
  • Beta (5Y Monthly) 0.91
  • PE Ratio (TTM) 18.57
  • EPS (TTM) 3.32
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield 0.80 (1.29%)
  • Ex-Dividend Date Feb 18, 2025
  • 1y Target Est 86.80

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen lysinate and ibuprofen sodium; and other APIs, including metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, paracetamol, etc. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals and Pharmaceuticals Limited provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, para amino phenol, and mono chloro acetic acid to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India.

www.iolcp.com

2,777

Full Time Employees

March 31

Fiscal Year Ends

Recent News: IOLCP.NS

View More

Performance Overview: IOLCP.NS

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

IOLCP.NS
24.37%
S&P BSE SENSEX (^BSESN)
3.82%

1-Year Return

IOLCP.NS
22.16%
S&P BSE SENSEX (^BSESN)
0.16%

3-Year Return

IOLCP.NS
36.82%
S&P BSE SENSEX (^BSESN)
27.46%

5-Year Return

IOLCP.NS
22.23%
S&P BSE SENSEX (^BSESN)
141.20%

Compare To: IOLCP.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IOLCP.NS

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    17.41B

  • Enterprise Value

    17.10B

  • Trailing P/E

    17.90

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.85

  • Price/Book (mrq)

    1.05

  • Enterprise Value/Revenue

    0.84

  • Enterprise Value/EBITDA

    8.17

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.73%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    20.55B

  • Net Income Avi to Common (ttm)

    972.7M

  • Diluted EPS (ttm)

    3.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.54B

  • Total Debt/Equity (mrq)

    7.74%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: IOLCP.NS

View More

Company Insights: IOLCP.NS

Research Reports: IOLCP.NS

View More

People Also Watch